ObsEva appoints industry expert as Chief Medical Officer to further advance its Phase 3 clinical programs

NEXT STORY
Basilea erweitert Phase-2-Studie mit Derazantinib beim intrahepatischen Gallengangskarzinom (iCCA) um Studienkohorte für Patienten mit Mutation oder Amplifikation des FGFR2-Gens
PREV STORY
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Viral Vector Manufacturing Market Report 2021: Market was Estimated at $450.5 Million in 2020 and is Projected to Reach a RevisedSize of $1.5 Billion by 2027

author_avatar
NASDAQ Market News

Clover Health, Mass. General, and ACP Decisions Research Team Secures Grant from National Institute of Health for Innovative Approach to Advance Care Planning

author_avatar
NASDAQ Market News

Roche’s risdiplam showed significant improvement in motor function in people aged 2-25 with type 2 or 3 spinal muscular atrophy

author_avatar
NASDAQ Market News